Aggressive relapse of multiple myeloma with intracerebral extension and associated hemorrhage. 2007

Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan

UI MeSH Term Description Entries
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002543 Cerebral Hemorrhage Bleeding into one or both CEREBRAL HEMISPHERES including the BASAL GANGLIA and the CEREBRAL CORTEX. It is often associated with HYPERTENSION and CRANIOCEREBRAL TRAUMA. Brain Hemorrhage, Cerebral,Cerebral Parenchymal Hemorrhage,Hemorrhage, Cerebral,Intracerebral Hemorrhage,Hemorrhage, Cerebrum,Brain Hemorrhages, Cerebral,Cerebral Brain Hemorrhage,Cerebral Brain Hemorrhages,Cerebral Hemorrhages,Cerebral Parenchymal Hemorrhages,Cerebrum Hemorrhage,Cerebrum Hemorrhages,Hemorrhage, Cerebral Brain,Hemorrhage, Cerebral Parenchymal,Hemorrhage, Intracerebral,Hemorrhages, Cerebral,Hemorrhages, Cerebral Brain,Hemorrhages, Cerebral Parenchymal,Hemorrhages, Cerebrum,Hemorrhages, Intracerebral,Intracerebral Hemorrhages,Parenchymal Hemorrhage, Cerebral,Parenchymal Hemorrhages, Cerebral
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
April 2014, Neurocritical care,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
January 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
March 2013, Stroke,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
October 2021, Neurocritical care,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
January 1998, Ryoikibetsu shokogun shirizu,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
March 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
January 2024, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
January 2008, Revista de neurologia,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
December 2014, Turkish journal of haematology : official journal of Turkish Society of Haematology,
Nishitha Reddy, and Ioannis Karampelas, and Asher Chanan-Khan, and Robert Fenstermaker, and Swami Padmanabhan
April 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!